2012
DOI: 10.1039/c2lc40338b
|View full text |Cite
|
Sign up to set email alerts
|

Formation and optogenetic control of engineered 3D skeletal muscle bioactuators

Abstract: Densely arrayed skeletal myotubes are activated individually and as a group using precise optical stimulation with high spatiotemporal resolution. Skeletal muscle myoblasts are genetically encoded to express light-activated cation channel, Channelrhodopsin-2, which allows for spatiotemporal coordination of the multitude of skeletal myotubes that contract in response to pulsed blue light. Furthermore, ensembles of mature functional 3D muscle microtissues have been formed from the optogenetically encoded myoblas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
249
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 245 publications
(260 citation statements)
references
References 53 publications
11
249
0
Order By: Relevance
“…Ion channels that respond to light stimuli have been implemented in a variety of applications that require cellular manipulation. Although the seminal studies in this field were performed on neurons, recent studies have demonstrated optogenetic approaches to control other cell types, including skeletal muscle (12). To implement optogenetic control of our muscle actuators, we used an existing lentiviral transduction protocol to engineer C2C12 murine myoblast cells with a mutated variant of the blue light-sensitive ion channel, Channelrhodopsin-2 (ChR2), namely ChR2(H134R) (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Ion channels that respond to light stimuli have been implemented in a variety of applications that require cellular manipulation. Although the seminal studies in this field were performed on neurons, recent studies have demonstrated optogenetic approaches to control other cell types, including skeletal muscle (12). To implement optogenetic control of our muscle actuators, we used an existing lentiviral transduction protocol to engineer C2C12 murine myoblast cells with a mutated variant of the blue light-sensitive ion channel, Channelrhodopsin-2 (ChR2), namely ChR2(H134R) (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Nearly all machines require actuators, modules that convert energy into motion, to produce a measurable output in response to input stimuli. Efforts to manufacture bio-integrated actuators have targeted a range of cell types (5), including flagellated bacteria (6), cardiac muscle (7)(8)(9), and skeletal muscle (10)(11)(12). We previously demonstrated a millimeter-scale soft robotic device, or biobot, that uses the contractile force produced by electrically paced skeletal muscle to drive locomotion across a substrate (10).…”
mentioning
confidence: 99%
“…The bioactuator was shown to generate passive tension forces comparable to other demonstrations of tissue engineered skeletal muscle. [118,119] The passive tension force generated could be increased by imposing a static mechanical stretch stimulus during differentiation, and by the addition of biochemical factors, such as human insulin-like growth factor 1 (IGF-1) to the differentiation medium. This was an important confirmation that the adaptive behavior inherent to natural biological systems could be mimicked in biohybrid systems cultured in vitro.…”
Section: Use Of Engineered Tissue As Biohybrid Machine Componentsmentioning
confidence: 99%
“…In particular, progress has been made in developing a model for skeletal muscle (Juhas et al, 2014;Sakar et al, 2012;Uzel et al, 2014), which could be useful for understanding and modeling dystrophic muscle diseases. Constrained microtissues also have been applied to model airway smooth muscle (West et al, 2013), aortic valve tissue (Kural and Billiar, 2016) and lung (Chen et al, 2016b).…”
Section: Implementation Of Mechanically Constrained Microtissues Withmentioning
confidence: 99%